pharma · Lupus Nephritis · Generalized Myasthenia Gravis · AUPH
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals trial registry — 19 ClinicalTrials.gov studies with program phase, status, and indication context.
Company details
- Status
- Public
- HQ
- 1196 Hwy 3 South, Northfield, MN 55057, US
- Founded
- 2007
- Employees
- 81
- Programs
- 14
- Drugs
- 10
- Patents
- 7
Aurinia Pharmaceuticals clinical trials
Registry index of 19 ClinicalTrials.gov studies linked to Aurinia Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.
Aurinia Pharmaceuticals trial registry — 19 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Aurinia Pharmaceuticals.
-
AUR-200-2024-02 — Phase 2
Clinical update -
voclosporin — Phase 3
Clinical update -
Voclosporin Ophthalmic Solution — Phase 2
Clinical update -
Voclosporin High Dose — Phase 2
Clinical update -
Simvastatin — Phase 1
Clinical update -
0.05% Voclosporin Ophthalmic Solution (VOS) — Phase 3
Clinical update -
Voclosporin — Phase 3
Clinical update -
Voclosporin — Phase 3
Clinical update